Cochrane has embarked on an important change programme to transform the way we produce high-quality, independent and timely evidence. The new model is designed to ensure Cochrane remains viable, sustainable, and focused on the greatest global health and care challenges now and into the future.
As part of the new model we are implementing a Central Editorial Service to streamline the editorial process. At the same time, from March 2023, Cochrane Review Groups in the UK will no longer receive NIHR funding. If you are an author currently writing a protocol, review, or update, we are working to ensure a smooth transition with minimal impact on your work.
We are very grateful to everyone who has contributed to Cochrane Gynaecological, Neuro-oncology and Orphan Cancers and very much hope that you will continue to give your time and expertise to Cochrane. We encourage you to look out for further communications about Cochrane's plans for the future and new opportunities to get involved. You can stay connected by:
• Following Cochrane on your favourite social media platform
• Opting in to Cochrane email communications in your Cochrane Account